• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON & CO. (SPARKS) BD BBL TRYPTICASE SOY AGAR W/5% SB(TSA II) /MAC II AGAR; CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON & CO. (SPARKS) BD BBL TRYPTICASE SOY AGAR W/5% SB(TSA II) /MAC II AGAR; CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL Back to Search Results
Model Number 221291
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problems No Patient Involvement (2645); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/21/2021
Event Type  malfunction  
Manufacturer Narrative
Date of event: unknown.The date received by manufacturer has been used for this field.Initial reporter phone #: (b)(4).A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.(b)(4).
 
Event Description
It was reported that the bd bbl¿ trypticase soy agar w/5% sb(tsa ii) /mac ii agar plates are contaminated.
 
Manufacturer Narrative
Investigation summary: during manufacturing of material 221291, media is formulated and sent through a high temperature short time sterilizer to remove bioburden.The petri dishes are subjected to uv radiation to decrease bioburden.The petri dishes are filled in a positive pressure hepa filtered environment.The filled plates are cooled and immediately wrapped into sleeves to decrease the introduction of microbes.Sleeves are then packaged into cartons and then transferred to a refrigerated truck (2 to 8 degrees c) for shipment to the distributor.Bd distributors are provided with the storage guidelines for the shipping and handling of bd media of 2 to 8 degrees c in a dark place.The batch history record for batch 0304047 was satisfactory and no quality notifications were generated during manufacturing and inspection.The release testing that is performed on this product does include physical attribute and bioburden testing.A sample of plates are incubated at 25 degrees c and at 35 degrees c for approximately 72 hours.All physical attribute and bioburden testing performed on this batch was satisfactory per bd internal procedures.Affected product does not have any sterility claims; the product is.Tested for bioburden prior to release to ensure that it conforms to product specifications.However, this does not ensure that the end-user will not receive a contaminated plate.The complaint history was reviewed.One other complaint has been taken on batch 0304047 for contamination and no other complaints have been taken on batch 0304047 for broken plates.Retention samples from batch 0304047 were not available for inspection.Two photos were received for investigation.One photo shows six opened bi-plates with bacterial colonies on at least one media of each plate.No returns were received for investigation.The other photo shows five opened plates from batch 0304047 (time stamps 0607, 0612 and 0613), the bottom of one plate with the plate print featured for batch verification (time stamp 0613) and a sleeve label from batch 0304047.The opened plates in the photo each have bacterial colonies growing on at least one media.No returns were received for investigation.No broken or cracked plates from batch 0304047 were shown in the photos.This complaint cannot be confirmed for broken plates.This complaint can be confirmed for contamination.Bd will continue to trend complaints for broken plates and contamination.Based on the low defect rate for this batch, no actions are planned at this time.
 
Event Description
It was reported that the bd bbl¿ trypticase soy agar w/5% sb(tsa ii) /mac ii agar plates are contaminated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD BBL TRYPTICASE SOY AGAR W/5% SB(TSA II) /MAC II AGAR
Type of Device
CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL
Manufacturer (Section D)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
MDR Report Key11316004
MDR Text Key242945810
Report Number1119779-2021-00293
Device Sequence Number1
Product Code JSG
UDI-Device Identifier10382902212918
UDI-Public10382902212918
Combination Product (y/n)N
PMA/PMN Number
PREAMENDMENT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 09/01/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date02/10/2021
Device Model Number221291
Device Catalogue Number221291
Device Lot Number0304047
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/21/2021
Initial Date FDA Received02/11/2021
Supplement Dates Manufacturer Received09/01/2021
Supplement Dates FDA Received09/15/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-